These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9443936)

  • 41. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
    Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
    J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antisense oligodeoxynucleotides downregulated c-sis mRNA expression to inhibit proliferation of vascular smooth muscle cells.
    Tang QD; Lin SG; Yu XY
    Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):36-42. PubMed ID: 10437122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of antisense oligomer in controlling c-raf.1 overexpression during diethylnitrosamine-induced hepatocarcinogenesis in rat.
    Das T; Patra F; Mukherjee B
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):309-18. PubMed ID: 19499222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
    Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
    J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
    Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
    Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
    Santiago FS; Atkins DG; Khachigian LM
    Am J Pathol; 1999 Sep; 155(3):897-905. PubMed ID: 10487847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
    Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
    Shi Y; Hutchinson HG; Hall DJ; Zalewski A
    Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization.
    Danis R; Criswell M; Orge F; Wancewicz E; Stecker K; Henry S; Monia B
    Curr Eye Res; 2003 Jan; 26(1):45-54. PubMed ID: 12789536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The reduction of Raf-1 protein by phosphorothioate ODNs and siRNAs targeted to the same two mRNA sequences.
    Lou TF; Gray CW; Gray DM
    Oligonucleotides; 2003; 13(5):313-24. PubMed ID: 15000822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.
    Müller M; Dietel M; Turzynski A; Wiechen K
    Int J Cancer; 1998 Aug; 77(4):567-71. PubMed ID: 9679760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A.
    Bönisch D; Weber AA; Wittpoth M; Osinski M; Schrör K
    Mol Pharmacol; 1998 Aug; 54(2):241-8. PubMed ID: 9687564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells.
    Delafontaine P; Anwar A; Lou H; Ku L
    J Clin Invest; 1996 Jan; 97(1):139-45. PubMed ID: 8550825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
    Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
    Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease.
    Green DW; Roh H; Pippin J; Drebin JA
    J Am Coll Surg; 2000 Jul; 191(1):93-105. PubMed ID: 10898188
    [No Abstract]   [Full Text] [Related]  

  • 56. Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats.
    Stepkowski SM; Qu X; Wang ME; Tian L; Chen W; Wancewicz EV; Johnston JF; Bennett CF; Monia BP
    Transplantation; 2000 Aug; 70(4):656-61. PubMed ID: 10972225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular pharmacology of p120 antisense oligodeoxynucleotide phosphorothioate ISIS 3466.
    Saijo Y; Perlaky L; Valdez BC; Wang H; Henning D; Busch H
    Oncol Res; 1993; 5(8):283-91. PubMed ID: 8012060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
    Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K
    Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.
    Yu SM; Chen SF; Lau YT; Yang CM; Chen JC
    Mol Pharmacol; 1996 Oct; 50(4):1000-9. PubMed ID: 8863847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides.
    Funato T; Kozawa K; Fujimaki S; Kaku M
    Anticancer Drugs; 2001 Apr; 12(4):325-9. PubMed ID: 11335788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.